๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
PHARMACOLOGY III 2nd course 4th Stage โใปโใปโใปโใปโ ุญุณุจ ุงูู
ุญุงุถุฑุงุช ุงูู
ูุญุฏุฉ ู ุงูู
ุนุชู
ุฏุฉ ูู ุงูุงู
ุชุญุงู ุงูุชูููู
ู 1. Anti inflammatory 2. Anti inflammatory Explainโท Exam โ 3. DMARD and GOUT Explainโท Exam โ 4. Drugs affecting bone metabolism Explainโท Examโฆ
ุจุงูุฑุณุงูุฉ ุงูู
ุซุจุชุฉ ููุงู ุดุบูุงุช
โค36โคโ๐ฅ7๐ญ3๐3๐1
A 70-year-old postmenopausal woman was recently diagnosed with osteoporosis. She has a history of esophagitis. What is the most appropriate pharmacologic treatment?
A) Alendronate
B) Risedronate
C) Zoledronic acid
D) Denosumab
And why
A) Alendronate
B) Risedronate
C) Zoledronic acid
D) Denosumab
And why
โค11๐2๐1
A 72-year-old postmenopausal woman with severe osteoporosis and a recent history of vertebral fracture presents for treatment. She has chronic kidney disease. Which of the following is the most appropriate pharmacologic therapy for this patient?
A) Alendronate
B) Risedronate
C) Zoledronic acid
D) Denosumab
Hmena, And why
A) Alendronate
B) Risedronate
C) Zoledronic acid
D) Denosumab
Hmena, And why
โค14๐4๐2
Which of the following is an intermediate acting insulin that is formed by the addition of zinc and protamine to regular insulin?
A. Insulin glargine
B. Insulin detemir
C. Aspart insulin
D. Insulin isophane
E. None of the above
It's easy
A. Insulin glargine
B. Insulin detemir
C. Aspart insulin
D. Insulin isophane
E. None of the above
It's easy
โค25๐ฅ4๐2โ1๐1
BN is a patient with type 2 diabetes who has a blood glucose of 350 mg/dL today at his office visit.
The physician would like to give some insulin to bring the glucose down before he leaves the office. Which of the following would is unappropriate for rapid lowering of blood glucose
level in BN?
A. Insulin aspart
B. Insulin glargine
C. Insulin glulisine
D. Regular insulin
E. Insulin lispro
The physician would like to give some insulin to bring the glucose down before he leaves the office. Which of the following would is unappropriate for rapid lowering of blood glucose
level in BN?
A. Insulin aspart
B. Insulin glargine
C. Insulin glulisine
D. Regular insulin
E. Insulin lispro
โค15๐3๐3โ2๐ฅ1
Regarding Neutral Protamine Hagedorm (NPH) insulin,
which of the following statements is not correct:
A. It is formed by the addition of zinc and protamine to regular insulin
B. Less solubility and delayed absorption contributes to its longer duration of action
C. It is used to control post-prandial glucose levels
D. Its other name is insulin isophane
E. It is not suitable for rapid lowering of glucose levels
which of the following statements is not correct:
A. It is formed by the addition of zinc and protamine to regular insulin
B. Less solubility and delayed absorption contributes to its longer duration of action
C. It is used to control post-prandial glucose levels
D. Its other name is insulin isophane
E. It is not suitable for rapid lowering of glucose levels
๐ฅ13โค11๐3
A 13-year-old boy with type 1 diabetes is brought to the hospital complaining of dizziness.
Laboratory findings include severe hyperglycemia, ketoacidosis, and a blood pH of 7.15. Which
of the following agents should be administered to achieve rapid control of the severe ketoacidosis in this diabetic boy?
A. Crystalline zinc insulin
B. Glyburide
C. Insulin glargine
D. NPH insulin
E. Insulin degludec
Laboratory findings include severe hyperglycemia, ketoacidosis, and a blood pH of 7.15. Which
of the following agents should be administered to achieve rapid control of the severe ketoacidosis in this diabetic boy?
A. Crystalline zinc insulin
B. Glyburide
C. Insulin glargine
D. NPH insulin
E. Insulin degludec
โค16๐ฅ3
All of the following statements regarding type 1 diabetes are true EXCEPT:
A. It is characterized by absolute lack of insulin
B. It mostly afflict children
C. ฮ-cell destruction is attributed to autoimmune processes
D. Genetic prediposition is very strong
E. Ketoacidosis is mostly encountered in type 1 diabetes
A. It is characterized by absolute lack of insulin
B. It mostly afflict children
C. ฮ-cell destruction is attributed to autoimmune processes
D. Genetic prediposition is very strong
E. Ketoacidosis is mostly encountered in type 1 diabetes
๐ฅ14โค5
ุงูุงูุณูููู ูููุฑุฒ ุฏุงุฎู ุฌุณู
ูู ุจุทุฑููุชูู:
ุงูุทุฑููุฉ ุงูุฃููู Basal insulin ุงู Foundation
ุจุญูุซ ุงู ุงูุจููุฑูุงุณ ููุฑุฒ ูู ูุฉ ู ุนููุฉ ูููููุฉ ู ู ุงู insulin ุนูู ู ุฏู ููู ูุงู ู
ูุฐุง ููุธู ู ุณุชูู ุงูุณูุฑ ุนูู ู ุฏู 24 ุณุงุนุฉ (ุงุซูุงุก ุงูููู ู ู ุง ุจูู ุงููุฌุจุงุช)
ุงูุทุฑููุฉ ุงูุซุงููุฉ Bolus insulin ุงู Prandial
ูุฐุง ูููุฑุฒ ู ุน ูู ูุฌุจุฉ ุจูู ูุงุช ุฃุนูู
ุชููุฑุฒ ูู ูุฉ ุจุนุฏ ุงู Breakfast
ุชููุฑุฒ ูู ูุฉ ุจุนุฏ ุงู lunch
ุชููุฑุฒ ูู ูุฉ ุจุนุฏ ุงู dinner
ุญุชู ูุงุฎุฐ ุงู glucose ุงูู ุฃุฎูุฐ ู ู ุงููุฌุจุฉ ููุฏุฎูู ููุฎูุงูุง
ุงูุง ุนูุฏู ูู ููุน ู ู ุงูุงูุณููููุ
Short acting insulin
Rabid acting insulin
Intermediate acting insulin
Long acting insulin
ููุณู ุงุฐุง ูุฑูุฏ ูุณูุทุฑ ุนูู ู ุณุชูู ุงูุณูุฑ ุจุนุฏ ุงูุทุนุงู ู ุจุงุดุฑุฉ
ุงูู ูุฑูุถ ููุทู ุงูุณูููู ุณุฑูุน ูุญุงูู ู ููุ
ูุญุงูู ุงู ูุดุงุจู ุงู Bolus insulin
ุงูู ููู ู ููุ
ููุด ูุฐููุ
Rapid-acting insulins are administered to mimic the
prandial (mealtime) release of insulin
ุญุชู ูุดุงุจูู ุงูุงูุณูููู ุงูู ูููุฑุฒ ุงุซูุงุก ุงููุฌุจุงุช
ูุจุงูุชุงููุ
control postprandial glucose levels
ุงุณูุทุฑ ุนูู ู ุณุชูู ุงูุณูุฑ ุจุนุฏ ุงููุฌุจุฉ
ุฒูู ุงุฐุง ุงุฑูุฏ ุงุณูุทุฑ ุนูู ู ุณุชูู ุงูุณูุฑ ุนูู ุทูู ุงูููู ุ
ูุนูู ู ุณุชูู ุงูุณูุฑ ูู ุญุงูุฉ ุงูุตูุงู ุงู Fasting
ููุง ุดูู ุงูู ูุฑูุถ ุงูุทูุ
ุงูู ูุฑูุถ ุงูุทู insulin ูุญุงูู ุงู ูุดุงุจู ุงู Basal insulin
ุงูู ููู ู ูู
ููุด ูุฐููุ
long-acting insulin used to control fasting glucose levels
ุญุชู ูุณูุทุฑู ุนูู ู ุณุชูู ุงูุณูุฑ ุงุซูุงุก ุงูููู ูู ุง ุจูู ุงููุฌุจุงุช
ูุนูู ูุดุงุจูู ุงู basal insulin
ููุทููู ู ุฑุฉ ูุญุฏุฉ ุจุงูููู ู ุง ุนุฏุง NPH ู ุฑุชูู ุจุงูููู
#diabetes
๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
ุงูุทุฑููุฉ ุงูุฃููู Basal insulin ุงู Foundation
ุจุญูุซ ุงู ุงูุจููุฑูุงุณ ููุฑุฒ ูู ูุฉ ู ุนููุฉ ูููููุฉ ู ู ุงู insulin ุนูู ู ุฏู ููู ูุงู ู
ูุฐุง ููุธู ู ุณุชูู ุงูุณูุฑ ุนูู ู ุฏู 24 ุณุงุนุฉ (ุงุซูุงุก ุงูููู ู ู ุง ุจูู ุงููุฌุจุงุช)
ุงูุทุฑููุฉ ุงูุซุงููุฉ Bolus insulin ุงู Prandial
ูุฐุง ูููุฑุฒ ู ุน ูู ูุฌุจุฉ ุจูู ูุงุช ุฃุนูู
ุชููุฑุฒ ูู ูุฉ ุจุนุฏ ุงู Breakfast
ุชููุฑุฒ ูู ูุฉ ุจุนุฏ ุงู lunch
ุชููุฑุฒ ูู ูุฉ ุจุนุฏ ุงู dinner
ุญุชู ูุงุฎุฐ ุงู glucose ุงูู ุฃุฎูุฐ ู ู ุงููุฌุจุฉ ููุฏุฎูู ููุฎูุงูุง
ุงูุง ุนูุฏู ูู ููุน ู ู ุงูุงูุณููููุ
Short acting insulin
Rabid acting insulin
Intermediate acting insulin
Long acting insulin
ููุณู ุงุฐุง ูุฑูุฏ ูุณูุทุฑ ุนูู ู ุณุชูู ุงูุณูุฑ ุจุนุฏ ุงูุทุนุงู ู ุจุงุดุฑุฉ
ุงูู ูุฑูุถ ููุทู ุงูุณูููู ุณุฑูุน ูุญุงูู ู ููุ
ูุญุงูู ุงู ูุดุงุจู ุงู Bolus insulin
ุงูู ููู ู ููุ
Rabid acting insulin
Lispro
Aspart
Glulisine
ูููุงูู ุงู Regular Insulin ุงูู ูู ุงู Short acting ุจุณ ูุฐุง ู ูุนููู ุงุจุทุฃ ูุฐูู ูุงุฒู ูุงุฎุฐููู ูุจู ุงููุฌุจุฉ ุจูุต ุณุงุนุฉ
ููุด ูุฐููุ
Rapid-acting insulins are administered to mimic the
prandial (mealtime) release of insulin
ุญุชู ูุดุงุจูู ุงูุงูุณูููู ุงูู ูููุฑุฒ ุงุซูุงุก ุงููุฌุจุงุช
ูุจุงูุชุงููุ
control postprandial glucose levels
ุงุณูุทุฑ ุนูู ู ุณุชูู ุงูุณูุฑ ุจุนุฏ ุงููุฌุจุฉ
ุฒูู ุงุฐุง ุงุฑูุฏ ุงุณูุทุฑ ุนูู ู ุณุชูู ุงูุณูุฑ ุนูู ุทูู ุงูููู ุ
ูุนูู ู ุณุชูู ุงูุณูุฑ ูู ุญุงูุฉ ุงูุตูุงู ุงู Fasting
ููุง ุดูู ุงูู ูุฑูุถ ุงูุทูุ
ุงูู ูุฑูุถ ุงูุทู insulin ูุญุงูู ุงู ูุดุงุจู ุงู Basal insulin
ุงูู ููู ู ูู
Long acting insulin
Glargine
Detemir
Degludec
ูููุงูู NPH
ููุด ูุฐููุ
long-acting insulin used to control fasting glucose levels
ุญุชู ูุณูุทุฑู ุนูู ู ุณุชูู ุงูุณูุฑ ุงุซูุงุก ุงูููู ูู ุง ุจูู ุงููุฌุจุงุช
ูุนูู ูุดุงุจูู ุงู basal insulin
ููุทููู ู ุฑุฉ ูุญุฏุฉ ุจุงูููู ู ุง ุนุฏุง NPH ู ุฑุชูู ุจุงูููู
#diabetes
๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
โค77๐7๐ฅ2๐2
IMP. cancer.pdf
2.5 MB
ุชุฃุดูุฑุงุช ููู
ูู
ุงุช ุจุฑุฃูู
ููู ุฑุงุฌุนุฉ ุงู ุงูุชุฑููุฒ ุน ุงูู ูู ุจุนุฏ ุงูู ุงู ุฏุฑุงุณุฉ ุงูุฌุงุจุชุฑ ุจุงููุงู ู
ูุนูู ู ู ุงุนุชู ุงุฏ ููู ุนููู ู ุฌุฑุฏ ู ุฑุงุฌุนุฉ
#cancer
ููู ุฑุงุฌุนุฉ ุงู ุงูุชุฑููุฒ ุน ุงูู ูู ุจุนุฏ ุงูู ุงู ุฏุฑุงุณุฉ ุงูุฌุงุจุชุฑ ุจุงููุงู ู
ูุนูู ู ู ุงุนุชู ุงุฏ ููู ุนููู ู ุฌุฑุฏ ู ุฑุงุฌุนุฉ
#cancer
โค58๐8๐ฅ3๐2๐1๐1๐ฏ1๐1
Adverse Effects of Drugs used in Osteoporosis
โญ Calcium supplementation
โญ Bisphosphonates:
โญ Denosumab:
โญ Parathyroid agents (Teriparatide, Abaloparatide)
โญ Raloxifene
โญ Calcitonin
#bone_metablism
๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
โญ Calcium supplementation
flatulence(gas)
bloating
ู ู ูู ูุชุฏุงุฎู ูู ุงู ุชุตุงุต
iron preparations
thyroid replacement
fluoroquinolone and tetracycline antibiotics
โญ Bisphosphonates:
More common:
Esophagitis
Esophageal ulcers
ูุงู ุจุงููุณุจุฉ ูู oral
ููููู ูุงู ุงูู ุดููุฉ ู ู ุฎูุงู ูุตุญ ุงูู ุฑูุถ ุงูู ูุจูู ุจูุถุน ู ุณุชููู upright ู ุน ุดุฑุจ ูู ูุงุช ู ู ุงูู ุงุก
ุจุนุฏ ู ู ูู ุชุณุจุจ
Diarrhea, abdominal pain and musculoskeletal pain
ุงูุงุณุชุฎุฏุงู ุงูู ุทูู ููุฐู ุงูุฅุฏููุฉ ูุณุจุจ
Osteo necrosis of the jaw
Atypical femur fractures
ูููููู ู ู ุฎูุงู ุงู drug holiday
โญ Denosumab:
More common :
Increased risk of infections
Dermatological reactions
Hypocalcemia
Less common:
Atypical femur fractures
Osteo necrosis of the jaw
โญ Parathyroid agents (Teriparatide, Abaloparatide)
Hypercalcemia
Orthostatic hypotension
Increased risk of osteosarcoma in rats
โญ Raloxifene
Hot flashes
Leg cramps
Venous thromboembolism
โญ Calcitonin
Rhinitis
other nasal symptoms
#bone_metablism
๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
๐ฅ35โค14๐6๐3๐2
Androgen.pdf
822.8 KB
โค33๐4๐4โคโ๐ฅ3
๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
Contraceptives.pdf
ุตุญุญููุง ูู
ูู
ูฃ ุณููุงุช
ุตุญุชุชูุง ุจุงูู ูู ๐ซก
ุดูุฑุง ููุชูุจูู
ูฃ ุณููุงุช
ุตุญุชุชูุง ุจุงูู ูู ๐ซก
ุดูุฑุง ููุชูุจูู
โค23
Which of the following drugs is cell cycleโspecific and effective in treating high-growth-fraction malignancies such as hematologic cancers?
A. Cisplatin
B. Nitrosoureas
C. Etoposide
D. Alkylating agents
Cell cycle non-specific drugs are effective for which of the following?
A. Only high-growth-fraction malignancies
B. Only hematologic cancers
C. Only solid tumors
D. Both low-growth-fraction and high-growth-fraction malignancies
A. Cisplatin
B. Nitrosoureas
C. Etoposide
D. Alkylating agents
Cell cycle non-specific drugs are effective for which of the following?
A. Only high-growth-fraction malignancies
B. Only hematologic cancers
C. Only solid tumors
D. Both low-growth-fraction and high-growth-fraction malignancies
โค13๐4๐4
๐๐ฅ๐ข๐ก ๐ฆ๐ง๐จ๐๐ฌ
Which of the following drugs is cell cycleโspecific and effective in treating high-growth-fraction malignancies such as hematologic cancers? A. Cisplatin B. Nitrosoureas C. Etoposide D. Alkylating agents Cell cycle non-specific drugs are effective for whichโฆ
So, this picture very important
โค61๐10๐3๐3๐ค3๐3๐1
ุดู ุดูุงุชูู ุจุงูุชุนูููุงุช
๐23โค11๐4๐3โ2๐1๐1
ุดุจุงุจ ุงูุงูุชุฑูุช ููุณุฏ ุจ ูฆ ุงูุตุจุญ
ุนูู ูุฏ ุงู ุชุญุงู ุงูุซุงูุซ ู ุชูุณุท
ุญู ููุง ุงูู ููุงุช ุงูู ุชุญุชุงุฌูููุง
ุนูู ูุฏ ุงู ุชุญุงู ุงูุซุงูุซ ู ุชูุณุท
ุญู ููุง ุงูู ููุงุช ุงูู ุชุญุชุงุฌูููุง
โค43๐ญ4๐ข2
ุงุฎูุงูู โฅ๏ธ
ุงููู ูููููู ููุณูู ุงู ุฑูู
๏ดฟ ุนูููููู ุชูููููููุชู ููุนูููููู ูููููุชูููููููู ุงูู ูุชูููููููููู ๏ดพ
ุงููู ูููููู ููุณูู ุงู ุฑูู
๏ดฟ ุนูููููู ุชูููููููุชู ููุนูููููู ูููููุชูููููููู ุงูู ูุชูููููููููู ๏ดพ
โค240๐18๐12โคโ๐ฅ8๐3
ุจุดุฑูุง ุดุจุงุจ
๐27๐12๐ข5โค4๐ฏ3โคโ๐ฅ1
ููุทุฉ 7
ู ู ูู ุชููู a ูู ู ูู e
ููุทุฉ 39
ุงุฎุชูุงุฑ B ุญุชู ูููู True ูุงุฒู ููุชุจ
Inhibit topoisomerase II
ุจุจููุฉ ู ุตุงุฏุฑ ุงูanthracyclines ุชุซุจุท ุงู 2
ุจููุฌ ุญุงูุฉ ููุง ูุตูุฑ ุญููุง all
ุจุณ ูู ูุงุชุจ 1
ุจุนุฏ ูู ูุงุฎุฐ ุน ุงูุนุงุฆูุฉ ุจุดูู ุนุงู antibiotics ููุตูุฑ ุญููุง E
ุงู ูุงุฎุฐ ููุท ุนุงุฆูุฉ ุงู anthracyclines
ูุงู ุจุงูุณุคุงู ู ุญุฏุฏ anthracyclines ูุนูู ู ู ูู ุงู antibiotic
ููุตูุฑ ุงูุฌูุงุจ B
ู ู ูู ุชููู a ูู ู ูู e
ููุทุฉ 39
ุงุฎุชูุงุฑ B ุญุชู ูููู True ูุงุฒู ููุชุจ
Inhibit topoisomerase II
ุจุจููุฉ ู ุตุงุฏุฑ ุงูanthracyclines ุชุซุจุท ุงู 2
ุจููุฌ ุญุงูุฉ ููุง ูุตูุฑ ุญููุง all
ุจุณ ูู ูุงุชุจ 1
ุจุนุฏ ูู ูุงุฎุฐ ุน ุงูุนุงุฆูุฉ ุจุดูู ุนุงู antibiotics ููุตูุฑ ุญููุง E
ุงู ูุงุฎุฐ ููุท ุนุงุฆูุฉ ุงู anthracyclines
ูุงู ุจุงูุณุคุงู ู ุญุฏุฏ anthracyclines ูุนูู ู ู ูู ุงู antibiotic
ููุตูุฑ ุงูุฌูุงุจ B
ูุนูู ุงูุญู ูุญุชู ู ุงุฌุงุจุชูู ู ุง ุงูุฏุฑ ุฃุฌุฒู ุจุงูุตุญ 100%
ูุฐุง ูุฑุฌุน ููู ุฎูู ุงูุณุคุงู ุดูู ุชูููุฑู
๐30โค3๐ฏ3๐2
ุงู ุดุงุก ุงููู ูููู
ูุงุฌุญูู ุดุจุงุจ ูุจุงูุชูุฏูุฑุงุช ูุงูุฏุฑุฌุงุช ุงูู ุชุฑุฏูููุง
ุงุชู ูู ู ุง ูุตุฑุช ููุงูู ุจุดู
ูุงุนุชุฐุฑ ุนู ุงู ูุตูุฑ (ุงุฐุง ุงุญุฏ ู ุชูุงุตู ููุงู ูู ุง ุฑุฏูุช ุนูููุ ุฅุฐุง ุณุคุงู ุจุงููุฑูุจ ู ุง ุงูุชุจูุช ุงููุ ุจุฏูู ูุตุฏ ุงููุฏ)
ุฑูุฒูุง ุจุจุงูู ุงูุงู ุชุญุงูุงุช ูุงู ุดุงุก ุงููู ู ุง ุจูู ุดู ูุชุฎูุตูู
ู ูููููโฅ๏ธ
ุงุชู ูู ู ุง ูุตุฑุช ููุงูู ุจุดู
ูุงุนุชุฐุฑ ุนู ุงู ูุตูุฑ (ุงุฐุง ุงุญุฏ ู ุชูุงุตู ููุงู ูู ุง ุฑุฏูุช ุนูููุ ุฅุฐุง ุณุคุงู ุจุงููุฑูุจ ู ุง ุงูุชุจูุช ุงููุ ุจุฏูู ูุตุฏ ุงููุฏ)
ุฑูุฒูุง ุจุจุงูู ุงูุงู ุชุญุงูุงุช ูุงู ุดุงุก ุงููู ู ุง ุจูู ุดู ูุชุฎูุตูู
ู ูููููโฅ๏ธ
โค302๐14๐8๐7๐ฏ6